194 related articles for article (PubMed ID: 18948117)
21. Nanomedicine and protein misfolding diseases.
Kransnoslobodtsev AV; Shlyakhtenko LS; Ukraintsev E; Zaikova TO; Keana JF; Lyubchenko YL
Nanomedicine; 2005 Dec; 1(4):300-5. PubMed ID: 16467913
[TBL] [Abstract][Full Text] [Related]
22. Novel Dimer Compounds That Bind α-Synuclein Can Rescue Cell Growth in a Yeast Model Overexpressing α-Synuclein. A Possible Prevention Strategy for Parkinson's Disease.
Kakish J; Allen KJ; Harkness TA; Krol ES; Lee JS
ACS Chem Neurosci; 2016 Dec; 7(12):1671-1680. PubMed ID: 27673434
[TBL] [Abstract][Full Text] [Related]
23. Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells.
Ugalde CL; Annesley SJ; Gordon SE; Mroczek K; Perugini MA; Lawson VA; Fisher PR; Finkelstein DI; Hill AF
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848207
[TBL] [Abstract][Full Text] [Related]
24. Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.
Luna E; Luk KC
FEBS Lett; 2015 Dec; 589(24 Pt A):3749-59. PubMed ID: 26505673
[TBL] [Abstract][Full Text] [Related]
25. A peptide-display protein scaffold to facilitate single molecule force studies of aggregation-prone peptides.
Doherty CPA; Young LM; Karamanos TK; Smith HI; Jackson MP; Radford SE; Brockwell DJ
Protein Sci; 2018 Jul; 27(7):1205-1217. PubMed ID: 29417650
[TBL] [Abstract][Full Text] [Related]
26. Detection of Misfolded α-Synuclein Aggregates in Cerebrospinal Fluid by the Protein Misfolding Cyclic Amplification Platform.
Concha-Marambio L; Shahnawaz M; Soto C
Methods Mol Biol; 2019; 1948():35-44. PubMed ID: 30771168
[TBL] [Abstract][Full Text] [Related]
27. High-speed atomic force microscopy reveals structural dynamics of α-synuclein monomers and dimers.
Zhang Y; Hashemi M; Lv Z; Williams B; Popov KI; Dokholyan NV; Lyubchenko YL
J Chem Phys; 2018 Mar; 148(12):123322. PubMed ID: 29604892
[TBL] [Abstract][Full Text] [Related]
28. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
Chaari A; Eliezer D; Ladjimi M
Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
[TBL] [Abstract][Full Text] [Related]
29. Anti-oligomeric single chain variable domain antibody differentially affects huntingtin and alpha-synuclein aggregates.
Nannenga BL; Zameer A; Sierks MR
FEBS Lett; 2008 Feb; 582(4):517-22. PubMed ID: 18230361
[TBL] [Abstract][Full Text] [Related]
30. α-Synuclein Misfolding Versus Aggregation Relevance to Parkinson's Disease: Critical Assessment and Modeling.
Berrocal R; Vasquez V; Rao Krs S; Gadad BS; Rao KS
Mol Neurobiol; 2015; 51(3):1417-31. PubMed ID: 25139280
[TBL] [Abstract][Full Text] [Related]
31. Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties.
Ulrih NP; Barry CH; Fink AL
Biochim Biophys Acta; 2008 Oct; 1782(10):581-5. PubMed ID: 18692132
[TBL] [Abstract][Full Text] [Related]
32. DJ-1, a Parkinson's disease related protein, aggregates under denaturing conditions and co-aggregates with α-synuclein through hydrophobic interaction.
Zhu M; H Patel S; Han S
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1759-1769. PubMed ID: 28330770
[TBL] [Abstract][Full Text] [Related]
33. Characterizing antibody specificity to different protein morphologies by AFM.
Wang MS; Zameer A; Emadi S; Sierks MR
Langmuir; 2009 Jan; 25(2):912-8. PubMed ID: 19090748
[TBL] [Abstract][Full Text] [Related]
34. Α-synuclein misfolding and Parkinson's disease.
Breydo L; Wu JW; Uversky VN
Biochim Biophys Acta; 2012 Feb; 1822(2):261-85. PubMed ID: 22024360
[TBL] [Abstract][Full Text] [Related]
35. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
Chaari A; Hoarau-Véchot J; Ladjimi M
Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
[TBL] [Abstract][Full Text] [Related]
36. The effect of fluorescent labeling on α-synuclein fibril morphology.
Mučibabić M; Apetri MM; Canters GW; Aartsma TJ
Biochim Biophys Acta; 2016 Oct; 1864(10):1419-27. PubMed ID: 27475048
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing normal and aggregated alpha-synuclein interaction on gold nanorod incorporated zinc oxide nanocomposite by electrochemical technique.
Adam H; Gopinath SCB; Arshad MKM; Parmin NA; Hashim U
Int J Biol Macromol; 2021 Feb; 171():217-224. PubMed ID: 33418041
[TBL] [Abstract][Full Text] [Related]
38. [Neurodegenerative conformational disease and its molecular bases].
Li WW; Cai DF; Ren HM
Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
[TBL] [Abstract][Full Text] [Related]
39. The aggregation and fibrillation of alpha-synuclein.
Fink AL
Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
[TBL] [Abstract][Full Text] [Related]
40. Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy.
Hoyer W; Cherny D; Subramaniam V; Jovin TM
J Mol Biol; 2004 Jun; 340(1):127-39. PubMed ID: 15184027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
